Polypill cuts CVD risk by one-third
Largest trial to date shows four in one pill effective for primary prevention: study
![assortment of pills](https://www.ausdoc.com.au/wp-content/uploads/2022/08/assorted_pills_dreamstime_l_136745745-2.jpg)
A polypill combining four cardiovascular drugs cut the risk of major cardiovascular events by a third over five years, a Lancet study finds.
The study looked at the effectiveness of the four-in-one pill in primary and secondary prevention of CVD in rural Iran.